ELAVL1 and metabolic dysfunction-associated steatotic liver disease: In addition, endoplasmic reticulum (ER) stress and dysregulated FXR signaling—both known to impair VLDL secretion and promote steatosis in MASLD [126]—were also observed in HuR-deficient livers [101].